Laboratory Corporation of America Holdings (0JSY.L)
USD 245.09
(1.2%)
USD 245.09
(1.2%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 474.6 Million USD | 0.85% |
| 2022 | 470.6 Million USD | 17.24% |
| 2021 | 401.4 Million USD | -5.15% |
| 2020 | 423.2 Million USD | 72.95% |
| 2019 | 244.7 Million USD | 3.12% |
| 2018 | 237.3 Million USD | 4.26% |
| 2017 | 227.6 Million USD | 10.92% |
| 2016 | 205.2 Million USD | 7.43% |
| 2015 | 191 Million USD | 36.92% |
| 2014 | 139.5 Million USD | 2.2% |
| 2013 | 136.5 Million USD | 12.81% |
| 2012 | 121 Million USD | 9.21% |
| 2011 | 110.8 Million USD | 7.16% |
| 2010 | 103.4 Million USD | 14.89% |
| 2009 | 90 Million USD | -1.1% |
| 2008 | 91 Million USD | 13.18% |
| 2007 | 80.4 Million USD | -4.63% |
| 2006 | 84.3 Million USD | 28.9% |
| 2005 | 65.4 Million USD | 6.34% |
| 2004 | 61.5 Million USD | 30.85% |
| 2003 | 47 Million USD | 4.91% |
| 2002 | 44.8 Million USD | 15.76% |
| 2001 | 38.7 Million USD | 22.47% |
| 2000 | 31.6 Million USD | 8.59% |
| 1999 | 29.1 Million USD | -5.21% |
| 1998 | 30.7 Million USD | -14.72% |
| 1997 | 36 Million USD | -18.74% |
| 1996 | 44.3 Million USD | -17.5% |
| 1995 | 53.7 Million USD | 167.16% |
| 1994 | 20.1 Million USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | 0.0% |
| 1990 | - USD | 0.0% |
| 1989 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 483.1 Million USD | 9.35% |
| 2024 Q1 | 441.8 Million USD | -6.99% |
| 2023 Q3 | 474.6 Million USD | 2.93% |
| 2023 Q1 | 487.8 Million USD | 1.33% |
| 2023 FY | 474.6 Million USD | 0.85% |
| 2023 Q4 | 475 Million USD | 0.08% |
| 2023 Q2 | 461.1 Million USD | -5.47% |
| 2022 Q4 | 481.4 Million USD | 2.29% |
| 2022 FY | 470.6 Million USD | 17.24% |
| 2022 Q2 | 467.7 Million USD | 7.2% |
| 2022 Q1 | 436.3 Million USD | -1.0% |
| 2022 Q3 | 470.6 Million USD | 0.62% |
| 2021 Q4 | 440.7 Million USD | 9.79% |
| 2021 FY | 401.4 Million USD | -5.15% |
| 2021 Q3 | 401.4 Million USD | -2.26% |
| 2021 Q2 | 410.7 Million USD | -2.52% |
| 2021 Q1 | 421.3 Million USD | -1.45% |
| 2020 Q3 | 423.2 Million USD | 7.82% |
| 2020 Q2 | 392.5 Million USD | 14.67% |
| 2020 Q4 | 427.5 Million USD | 1.02% |
| 2020 Q1 | 342.3 Million USD | 34.76% |
| 2020 FY | 423.2 Million USD | 72.95% |
| 2019 Q3 | 244.7 Million USD | 4.17% |
| 2019 Q4 | 254 Million USD | 3.8% |
| 2019 Q2 | 234.9 Million USD | 6.92% |
| 2019 FY | 244.7 Million USD | 3.12% |
| 2019 Q1 | 219.7 Million USD | -5.99% |
| 2018 Q3 | 237.3 Million USD | 1.85% |
| 2018 Q1 | 230.7 Million USD | 1.99% |
| 2018 FY | 237.3 Million USD | 4.26% |
| 2018 Q4 | 233.7 Million USD | -1.52% |
| 2018 Q2 | 233 Million USD | 1.0% |
| 2017 Q3 | 227.6 Million USD | 4.79% |
| 2017 Q4 | 226.2 Million USD | -0.62% |
| 2017 Q2 | 217.2 Million USD | 3.48% |
| 2017 Q1 | 209.9 Million USD | 5.06% |
| 2017 FY | 227.6 Million USD | 10.92% |
| 2016 Q2 | 198.8 Million USD | 4.85% |
| 2016 Q3 | 205.2 Million USD | 3.22% |
| 2016 Q4 | 199.8 Million USD | -2.63% |
| 2016 FY | 205.2 Million USD | 7.43% |
| 2016 Q1 | 189.6 Million USD | 0.74% |
| 2015 Q3 | 191 Million USD | 5.18% |
| 2015 Q2 | 181.6 Million USD | -0.22% |
| 2015 Q1 | 182 Million USD | -2.41% |
| 2015 FY | 191 Million USD | 36.92% |
| 2015 Q4 | 188.2 Million USD | -1.47% |
| 2014 Q4 | 186.5 Million USD | 33.69% |
| 2014 FY | 139.5 Million USD | 2.2% |
| 2014 Q3 | 139.5 Million USD | 0.5% |
| 2014 Q1 | 134.5 Million USD | -0.22% |
| 2014 Q2 | 138.8 Million USD | 3.2% |
| 2013 FY | 136.5 Million USD | 12.81% |
| 2013 Q3 | 136.5 Million USD | 7.91% |
| 2013 Q2 | 126.5 Million USD | 0.08% |
| 2013 Q4 | 134.8 Million USD | -1.25% |
| 2013 Q1 | 126.4 Million USD | 1.94% |
| 2012 FY | 121 Million USD | 9.21% |
| 2012 Q4 | 124 Million USD | 2.48% |
| 2012 Q1 | 114 Million USD | 6.54% |
| 2012 Q2 | 118.9 Million USD | 4.3% |
| 2012 Q3 | 121 Million USD | 1.77% |
| 2011 Q4 | 107 Million USD | -3.43% |
| 2011 FY | 110.8 Million USD | 7.16% |
| 2011 Q2 | 103.8 Million USD | -2.81% |
| 2011 Q1 | 106.8 Million USD | 8.98% |
| 2011 Q3 | 110.8 Million USD | 6.74% |
| 2010 Q1 | 86.3 Million USD | 4.61% |
| 2010 Q2 | 88.2 Million USD | 2.2% |
| 2010 Q4 | 98 Million USD | -5.22% |
| 2010 Q3 | 103.4 Million USD | 17.23% |
| 2010 FY | 103.4 Million USD | 14.89% |
| 2009 Q3 | 90 Million USD | 10.29% |
| 2009 Q1 | 71.2 Million USD | -8.48% |
| 2009 Q2 | 81.6 Million USD | 14.61% |
| 2009 FY | 90 Million USD | -1.1% |
| 2009 Q4 | 82.5 Million USD | -8.33% |
| 2008 Q3 | 91 Million USD | 4.12% |
| 2008 FY | 91 Million USD | 13.18% |
| 2008 Q1 | 85 Million USD | 2.16% |
| 2008 Q2 | 87.4 Million USD | 2.82% |
| 2008 Q4 | 77.8 Million USD | -14.51% |
| 2007 Q4 | 83.2 Million USD | 3.48% |
| 2007 Q3 | 80.4 Million USD | -2.55% |
| 2007 Q1 | 81.7 Million USD | 5.01% |
| 2007 FY | 80.4 Million USD | -4.63% |
| 2007 Q2 | 82.5 Million USD | 0.98% |
| 2006 Q3 | 84.3 Million USD | 11.66% |
| 2006 Q4 | 77.8 Million USD | -7.71% |
| 2006 FY | 84.3 Million USD | 28.9% |
| 2006 Q1 | 76.2 Million USD | 27.42% |
| 2006 Q2 | 75.5 Million USD | -0.92% |
| 2005 Q4 | 59.8 Million USD | -8.56% |
| 2005 FY | 65.4 Million USD | 6.34% |
| 2005 Q1 | 59.7 Million USD | 8.94% |
| 2005 Q2 | 53.6 Million USD | -10.22% |
| 2005 Q3 | 65.4 Million USD | 22.01% |
| 2004 Q2 | 51.9 Million USD | 8.58% |
| 2004 Q1 | 47.8 Million USD | 0.42% |
| 2004 Q4 | 54.8 Million USD | -10.89% |
| 2004 FY | 61.5 Million USD | 30.85% |
| 2004 Q3 | 61.5 Million USD | 18.5% |
| 2003 Q1 | 49.4 Million USD | 0.61% |
| 2003 FY | 47 Million USD | 4.91% |
| 2003 Q4 | 47.6 Million USD | 1.28% |
| 2003 Q3 | 47 Million USD | -3.09% |
| 2003 Q2 | 48.5 Million USD | -1.82% |
| 2002 Q1 | 42.8 Million USD | 6.73% |
| 2002 Q2 | 44 Million USD | 2.8% |
| 2002 Q3 | 44.8 Million USD | 1.82% |
| 2002 Q4 | 49.1 Million USD | 9.6% |
| 2002 FY | 44.8 Million USD | 15.76% |
| 2001 FY | 38.7 Million USD | 22.47% |
| 2001 Q2 | 37.4 Million USD | 7.47% |
| 2001 Q1 | 34.8 Million USD | 8.07% |
| 2001 Q3 | 38.7 Million USD | 3.48% |
| 2001 Q4 | 40.1 Million USD | 3.62% |
| 2000 FY | 31.6 Million USD | 8.59% |
| 2000 Q1 | 30.6 Million USD | 16.79% |
| 2000 Q4 | 32.2 Million USD | 1.9% |
| 2000 Q3 | 31.6 Million USD | -2.47% |
| 2000 Q2 | 32.4 Million USD | 5.88% |
| 1999 Q2 | 26.4 Million USD | -6.38% |
| 1999 Q4 | 26.2 Million USD | -9.97% |
| 1999 Q3 | 29.1 Million USD | 10.23% |
| 1999 Q1 | 28.2 Million USD | -7.24% |
| 1999 FY | 29.1 Million USD | -5.21% |
| 1998 Q4 | 30.4 Million USD | -0.98% |
| 1998 Q3 | 30.7 Million USD | 6.6% |
| 1998 Q1 | 29.9 Million USD | -0.99% |
| 1998 Q2 | 28.8 Million USD | -3.68% |
| 1998 FY | 30.7 Million USD | -14.72% |
| 1997 Q2 | 38.6 Million USD | -5.62% |
| 1997 Q3 | 36 Million USD | -6.74% |
| 1997 Q4 | 30.2 Million USD | -16.11% |
| 1997 Q1 | 40.9 Million USD | -5.1% |
| 1997 FY | 36 Million USD | -18.74% |
| 1996 FY | 44.3 Million USD | -17.5% |
| 1996 Q1 | 53.9 Million USD | -15.25% |
| 1996 Q2 | 45.8 Million USD | -15.03% |
| 1996 Q3 | 44.3 Million USD | -3.28% |
| 1996 Q4 | 43.1 Million USD | -2.71% |
| 1995 Q3 | 53.7 Million USD | -1.1% |
| 1995 Q4 | 63.6 Million USD | 18.44% |
| 1995 Q1 | 51.9 Million USD | 158.21% |
| 1995 FY | 53.7 Million USD | 167.16% |
| 1995 Q2 | 54.3 Million USD | 4.62% |
| 1994 Q3 | 20.1 Million USD | 0.0% |
| 1994 FY | 20.1 Million USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q4 | 20.1 Million USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Phreesia, Inc. | - USD | -Infinity% |
| Accuray Incorporated | 138.32 Million USD | -243.107% |
| Align Technology, Inc. | 296.9 Million USD | -59.851% |
| Elevance Health Inc. | -46.33 Billion USD | 101.024% |
| AxoGen, Inc. | 23.02 Million USD | -1961.685% |
| Boston Scientific Corporation | 2.48 Billion USD | 80.894% |
| CVS Health Corporation | 18.02 Billion USD | 97.367% |
| Cardinal Health, Inc. | 14.95 Billion USD | 96.827% |
| Centene Corporation | - USD | -Infinity% |
| DaVita Inc. | 143.1 Million USD | -231.645% |
| HCA Healthcare, Inc. | 2.02 Billion USD | 76.517% |
| Hologic, Inc. | 679.8 Million USD | 30.185% |
| Humana Inc. | - USD | -Infinity% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | -24.802% |
| Masimo Corporation | 545 Million USD | 12.917% |
| McKesson Corporation | 21.13 Billion USD | 97.755% |
| Patterson Companies, Inc. | 782.89 Million USD | 39.379% |
| Quest Diagnostics Incorporated | 190 Million USD | -149.789% |
| ResMed Inc. | 822.25 Million USD | 42.28% |
| Henry Schein, Inc. | 1.81 Billion USD | 73.851% |
| Teladoc Health, Inc. | 29.51 Million USD | -1508.105% |
| Universal Health Services, Inc. | 216.98 Million USD | -118.722% |
| Veeva Systems Inc. | - USD | -Infinity% |
| Baxter International Inc. | 2.82 Billion USD | 83.194% |
| Becton, Dickinson and Company | 3.27 Billion USD | 85.5% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 61.117% |
| Danaher Corporation | 2.59 Billion USD | 81.704% |
| Stryker Corporation | 4.84 Billion USD | 90.2% |
| Medtronic plc | 5.21 Billion USD | 90.903% |